A meta-analysis on the effect of sodium glucose cotransporter-2 inhibitor (SGLT-2 i) on metabolic parameters in patients with polycystic ovary syndrome (PCOS)
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'A meta-analysis was conducted using the Cochrane Library database as citation identifier. The disease under question was polycystic ovary syndrome and the intervention under scrutiny was SGLT-2 inhibitors' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["Polycystic ovary disease"]} <|eot_id|>
 Here is the Description of a dataset. Description:'A meta-analysis was conducted using the Cochrane Library database as citation identifier. The disease under question was polycystic ovary syndrome and the intervention under scrutiny was SGLT-2 inhibitors' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
A meta-analysis was conducted using the Cochrane Library database as citation identifier. The disease under question was polycystic ovary syndrome and the intervention under scrutiny was SGLT-2 inhibitors
Polycystic ovary disease